...
首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >The pathological evaluation of nonneoplastic kidney disorder in tumor nephrectomy specimens
【24h】

The pathological evaluation of nonneoplastic kidney disorder in tumor nephrectomy specimens

机译:肿瘤切除术标本中非肿瘤性肾脏疾病的病理学评估

获取原文

摘要

Renal cell carcinoma (RCC) comprises 2%-3% of all visceral and 80%-85% of all adult kidney malignancies. Nephrectomy is the treatment of choice for renal tumors. The accurate pathological evaluation of nonneoplastic renal parenchyma in nephrectomy specimens is important for subsequent management. Eighty-two patients with RCC who underwent surgery at Imam Khomeini Hospital, Urmia, Iran, from April 2006 to February 2015 were studied. Paraffin blocks of the hospital archives were stained by hematoxylin and eosin (H and E) and periodic acid-Schiff staining. Microscopic examination was performed on nontumoral portions that were in the farthest possible distance from the tumor. Out of total 82 cases, 24 (29.3%) had normal renal parenchyma and 58 (70.7%) had pathological changes in renal parenchyma. The most frequent pathological findings were vascular sclerosis with parenchymal scarring and pyelonephritis. Other findings include focal and diffuse mesangial hypercellularity, eight; focal segmental glome-rulonephritis, five; membranoproliferative glomerulonephritis, three; and membranous glome-rulonephritis, two. Parenchymal scarring and vascular change included 36% of clear cell type, 41% of papillary type, and 53.8% of chromophobe type. Although there is not any statistical relation between the gender of patients and pathological findings, there was an obvious correlation between age and pathological findings. Before the age of 55 years, vascular sclerosis with parenchymal scarring and glomerular diseases and then chronic pyelonephritis are more prevalent.Evaluation of pathological changes in nonneo-plastic renal parenchyma is an essential step in recognizing patients at risk of accelerated functional failure of the single remaining kidney, particularly in patients with a background of chronic vascular injury associated with diabetes or hypertension.
机译:肾细胞癌(RCC)占所有内脏的2%-3%和所有成人肾脏恶性肿瘤的80%-85%。肾切除术是肾脏肿瘤的首选治疗方法。肾切除标本中非肿瘤性肾实质的准确病理评估对于后续治疗很重要。研究对象为2006年4月至2015年2月在伊朗乌尔米亚伊玛目霍梅尼医院接受手术的82例RCC患者。医院档案的石蜡块用苏木精和曙红(H和E)以及高碘酸-希夫(Schiff)染色进行染色。在距肿瘤尽可能远的非肿瘤部位进行显微镜检查。在82例中,肾实质正常的24例(29.3%),肾实质病理改变的58例(70.7%)。最常见的病理结果是血管硬化伴实质性瘢痕和肾盂肾炎。其他发现包括局灶性和弥漫性肾小球系膜细胞过多,8。局灶性节段性肾小球肾炎,五个;膜增生性肾小球肾炎,三级;和膜性肾小球肾炎,两种。实质性瘢痕形​​成和血管变化包括透明细胞类型的36%,乳头状类型的41%和发色团类型的53.8%。尽管患者的性别与病理结果之间没有任何统计关系,但年龄与病理结果之间存在明显的相关性。在55岁之前,血管硬化伴有实质性瘢痕形​​成和肾小球疾病,然后是慢性肾盂肾炎更为普遍。评估非肿瘤性肾实质的病理变化是识别患者中存在剩余单个器官加速功能衰竭风险的重要步骤肾脏,尤其是患有与糖尿病或高血压相关的慢性血管损伤背景的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号